M
Magdalena Daccord
Publications - 8
Citations - 128
Magdalena Daccord is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 40 citations.
Papers
More filters
Journal ArticleDOI
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic.
Maciej Banach,Peter E. Penson,Zlatko Fras,Michal Vrablík,Daniel Pella,Željko Reiner,Seyed Mohammad Nabavi,Amirhossein Sahebkar,Meral Kayıkçıoğlu,Magdalena Daccord,FH Europe +10 more
TL;DR: The implications of COVID-19 infections for FH patients, the importance of continuing lipid-lowering therapy where possible, issues relating to safety monitoring and service delivery are discussed, and the evidence for additional benefits of statins and other lipid- Lowering drugs during viral infections is summarized.
Journal ArticleDOI
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
David Marais,Zeljko Reiner,Matteo Pirro,Manfredi Rizzo,Alexandros Sachinidis,Dan Gaita,Mohsen Mazidi,Daniel Pella,G.B. John Mancini,Stephan von Haehling,Maciej Banach,Julio Acosta,Mutaz Alkhnifsawi,Fahad Alnouri,Fahma Amar,Atanas G. Atanasov,G. Bajraktari,Sonu Bhaskar,Ibadete Bytyçi,Bojko Bjelakovic,Eric Bruckert,Alberto Cafferata,Richard Ceska,Arrigo F G Cicero,Xavier Collet,Magdalena Daccord,Olivier S. Descamps,Dragan Djuric,Ronen Durst,Marat V. Ezhov,Zlatko Fras,Adrian V. Hernandez,Steven P. Jones,Jacek Jerzy Jozwiak,N. Kakauridze,A. Kallel,Niki Katsiki,Amit Khera,Karam Kostner,Raimondas Kubilius,Gustavs Latkovskis,A. David Marais,Seth S. Martin,Julio A. Martínez,Dimitri P. Mikhailidis,Erkin M. Mirrakhimov,André R. Miserez,Olena Mitchenko,N.P. Mitkovskaya,Patrick M. Moriarty,Seyed Mohammad Nabavi,Devaki Nair,Demosthenes B. Panagiotakos,György Paragh,Peter E. Penson,Zaneta Petrulioniene,Arman Postadzhiyan,Raman Puri,Ashraf Reda,Dina Radenkovic,Michael Robert Rakowski,Jemaa Riadh,Dimitri Richter,Massimiliano Ruscica,Amirhossein Sahebkar,Naveed Sattar,Maria-Corina Serban,Abdullah Shehab,Aleksandr B Shek,Cesare R. Sirtori,Claudia Stefanutti,Tomasz Tomasik,Peter P. Toth,Margus Viigimaa,Pedro Valdivielso,Dragos Vinereanu,Branislav Vohnout,Michal Vrablík,Nathan D. Wong,Hung-I Yeh,Ji Zhisheng,Andreas Zirlik +81 more
TL;DR: A step‐by‐step patient‐centred approach to the identification and management of SAMS with a particular focus on strategies to prevent and manage the nocebo/drucebo effect and to improve long‐term compliance with lipid‐lowering therapy is presented.
Journal ArticleDOI
Paediatric familial hypercholesterolaemia screening in europe - public policy background and recommendations.
Samuel S. Gidding,Albert Wiegman,Urh Groselj,Tomáš Freiberger,Noël Peretti,Kanika I. Dharmayat,Magdalena Daccord,Nicola Bedlington,J. Sikonja,Kausik K. Ray,Raul D. Santos,Martin Halle,Lâle Tokgözoğlu,Iñaki Gutiérrez-Ibarluzea,Fausto J. Pinto,Marius Geanta +15 more
TL;DR: Recommendations presented herein to improve identification of FH emphasize that every country should have an FH screening programme and these programmes should be adapted from existing strategies to best fit the individual country's healthcare system.
Journal ArticleDOI
World Heart Federation Cholesterol Roadmap 2022
Kausik K. Ray,Brian A. Ference,Tania Séverin,Dirk Blom,Stephen J. Nicholls,Mariko H. Shiba,Wael Almahmeed,Rodrigo Alonso,Magdalena Daccord,Marat V. Ezhov,Rosa Fernández Olmo,Piotr Jankowski,Fernando Lanas,Roopa Mehta,Raman Puri,Nathan D. Wong,David A. Wood,Dongni Zhao,Samuel S. Gidding,Salim S. Virani,D. Lloyd-Jones,Fausto Eduardo Menon Pinto,Pablo Perel,Raul D. Santos +23 more
TL;DR: The present update of the World Heart Federation Cholesterol Roadmap provides a conceptual framework for the development of national policies and health systems approaches, so that potential roadblocks to cholesterol management and thus ASCVD prevention can be overcome.
Journal ArticleDOI
How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?
Alberico L. Catapano,Magdalena Daccord,Elaine Damato,Steve E. Humphries,R. Dermot G. Neely,Børge G. Nordestgaard,Michele Pistollato,Elisabeth Steinhagen-Thiessen +7 more
TL;DR: In this paper , the authors investigated the clinical utility for patients, and the economic benefit to healthcare systems and society of measuring Lp(a) concentrations more widely today, and found that if Lp (a) concentration is measured more widely, patients, healthcare system and society would experience clinical and economic benefits even before specific Lp lowering pharmacological treatments become available.